Chao Zhao
- Oncology top 1%
- Lung Cancer Research Studies 39
- Cancer Immunotherapy and Biomarkers 34
- Colorectal Cancer Treatments and Studies 11
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 20
-
- Lung Cancer Treatments and Mutations 79
- Brain Metastases and Treatment 8
- Lung Cancer Diagnosis and Treatment 7
- Immunology top 5%
- Hepatology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chao Zhao
121 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 105
- Oncology 2.3k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 2.0k
- Immunology 479
- Hepatology 171
Countries citing papers authored by Chao Zhao
This map shows the geographic impact of Chao Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Zhao more than expected).
Fields of papers citing papers by Chao Zhao
This network shows the impact of papers produced by Chao Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Zhao. The network helps show where Chao Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chao Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 11 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 18 | |
| 14 | PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases | 2020 | 1 |
| 15 | High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer | 2019 | 1 |
| 16 | 2019 | 121 | |
| 17 | 2019 | 23 | |
| 18 | 2018 | 12 | |
| 19 | 2018 | 34 | |
| 20 | 2018 | 2 |
About Chao Zhao
Chao Zhao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 132 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (79 papers), Lung Cancer Research Studies (39 papers), Cancer Immunotherapy and Biomarkers (34 papers), Cancer Genomics and Diagnostics (20 papers), Colorectal Cancer Treatments and Studies (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Brain Metastases and Treatment (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.0k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Chao Zhao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuefei Li, Shengxiang Ren, Chunxia Su, Tao Jiang, Xiaoxia Chen, Fei Zhou, Guanghui Gao, Meng Qiao, Caicun Zhou and Weijing Cai. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.